Evidence map›Paper›PMID 39330001›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

A Non-Randomized Comparison of Online and In-Person Formats of the Canadian Androgen Deprivation Therapy Educational Program: Impacts on Side Effects, Bother, and Self-Efficacy.

Lauren M Walker, Carly S Sears, Erik Wibowo, John W Robinson, Andrew G Matthew, Deborah L McLeod, Richard J Wassersug

Abstract readComparative Study
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lauren M WalkerDivision of Psychosocial Oncology, Department of Oncology, University of Calgary, Calgary, AB T2N 4N1, Canada.
Carly S SearsDivision of Psychosocial Oncology, Department of Oncology, University of Calgary, Calgary, AB T2N 4N1, Canada.ORCID 0000-0003-2353-5051
Erik WibowoSchool of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney 2006, Australia.
John W RobinsonDivision of Psychosocial Oncology, Department of Oncology, University of Calgary, Calgary, AB T2N 4N1, Canada.
Andrew G MatthewDivision of Urology, Department of Surgery, University of Toronto, Toronto, ON M5T 2SB, Canada.
Deborah L McLeodSchool of Nursing, Faculty of Health, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Richard J WassersugCellular & Physiological Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 2A1, Canada.ORCID 0000-0001-7028-7615

Funding

Astellas Pharma (Canada) Unrestricted Educational GrantTolmar Pharmaceuticals Canada Inc. Unrestricted Educational Grant
6 · The paper itself

Abstract

Although Androgen Deprivation Therapy (ADT) is effective in controlling prostate cancer (PCa) and increasing survival, it is associated with a myriad of side effects that cause significant morbidity. Previous research has shown that PCa patients starting on ADT are neither fully informed nor well-equipped to manage the breadth of ADT's side effects. The ADT Educational Program (a 1.5 h interactive class plus a book) was developed as an evidence-based resource for patients dealing with ADT. Our aim here was to compare the efficacy of an online version of the class with a previously assessed in-person version of the class. Using mixed MANOVAs within a non-randomized comparison design, we assessed: (1) changes in patients' experiences of self-efficacy to manage and bother associated with side effects approximately 10 weeks after attending a class, and (2) potential differences in these variables between online and in-person class formats. Side effect bother decreased from pre- to post-class but did not differ between in-person (

Indexed as

Androgen AntagonistsProstatic NeoplasmsSelf EfficacyAgedCanadaHumansMaleMiddle AgedPatient Education as TopicAndrogen Antagonistsandrogen deprivation therapypatient educationprostate cancerpsychosocial oncologyself-efficacyside effect management

Identifiers

PMID39330001
PMCPMC11431469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.